ClarenceWLegertonIIIMD

Rheumatology • Summerville, SC

Rheumatoid Arthritis & Related

Managing Partner, Articularis Healthcare Charleston, SC

Join to view full profile

Dr. Legerton is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Legerton's full profile

Already have an account?

Office
2001 2nd Ave
Ste 201
Summerville, SC 29486
Phone+1 843-572-4840

Fax+1 843-764-2726

Education & Training

Vanderbilt University Medical CenterResidency, Internal Medicine, 1986 - 1989
Medical University of South CarolinaClass of 1986

Certifications & Licensure

SC State Medical License 1992 - 2025
TN State Medical License 1989 - 1992
American Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

Fellow (FACR) American College of Rheumatology

Clinical Trials

Phase IIB Dose Ranging Study in Subjects With Moderate to Severe Rheumatoid Arthritis Start of enrollment: 2012 Jun 01
Completed
Phase 2
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus Start of enrollment: 2014 Jan 01
Terminated
Phase 3
A Study of LY3337641 in Rheumatoid Arthritis Start of enrollment: 2016 Aug 22
Terminated
Phase 2
A Study of Ixekizumab (LY2439821) in bDMARD-Naive Participants With Radiographic Axial Spondyloarthritis Start of enrollment: 2016 May 02
Completed
Phase 3
A Study of Ixekizumab (LY2439821) in TNF Inhibitor Experienced Participants With Radiographic Axial Spondyloarthritis Start of enrollment: 2016 Apr 12
Completed
Phase 3
A Long Term Extension Study of Ixekizumab (LY2439821) in Participants With Axial Spondyloarthritis Start of enrollment: 2017 May 09
Completed
Phase 3
Join now to see all

Publications & Presentations

PubMed

153 citations
Subcutaneous abatacept versus intravenous abatacept: a phase IIIb noninferiority study in patients with an inadequate response to methotrexate.
Mark C. Genovese, A. Covarrubias, Gustavo Leon, Eduardo Mysler, M. Keiserman
Arthritis and Rheumatism. 2011-10-01
179 citations
Impact of T-cell costimulation modulation in patients with undifferentiated inflammatory arthritis or very early rheumatoid arthritis: a clinical and imaging study of ...
Paul Emery, Patrick Durez, Maxime Dougados, Clarence W. Legerton, Jean-Claude Becker
Annals of the Rheumatic Diseases. 2010-03-01
22 citations
Longterm Safety and Efficacy of Subcutaneous Abatacept in Patients with Rheumatoid Arthritis: 5-year Results from a Phase IIIb Trial.
Mark C. Genovese, César Pacheco-Tena, A. Covarrubias, Gustavo Leon, Eduardo Mysler
The Journal of Rheumatology. 2018-04-15

Lectures

4th Annual Essentials in Primary Care Summer Conference - Session 2
Continuing Education Company Inc, Kiawah Island, South Carolina - 7/29/2013
20th Annual Primary Care CME Conference Kiawah Island, South Carolina
Continuing Education Company Inc, Kiawah Island, South Carolina - 7/2/2012
20th Annual Primary Care Conference 2012
Continuing Education Company Inc, Kiawah Island, South Carolina - 7/2/2012

Professional Memberships

American College of Physicians - ACP
Member
American College of Rheumatology - ACR
Fellow